LAMOTRIGINE
Order Name
LAM
Athena Orderable:
Lamotrigine-S [amgw]
Revision Date 09/04/2020
Athena Orderable:
Lamotrigine-S [amgw]
Revision Date 09/04/2020
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
LAMOTRIGINE
|
Quantitative Enzyme Immunoassay | 6948-4 |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | See Instructions | Frozen | ||
| Instructions | RML test code: 4310575
Click here to view information on the RML website. **Indicate collection time and time of last dose. Separate from cells ASAP. |
|||
| GENERAL INFORMATION | |
|---|---|
| Testing Schedule | M-F at Reference Facility |
| Expected TAT | 1-3 days |
| Clinical Use | Lamotrigine is an anticonvulsant drug used for the treatment of epilepsy. In addition, to its anticonvulsant properties, it is approved for the maintenance treatment of bipolar type I disorder. With monotherapy, lamotrigine has relatively few side-effects and generally doesn't lead to toxicity. However, clearance is altered by several other compounds an combination therapy with other anticonvulsant drugs can have a substantial effect on the clearnce of this drug. |
| Rejection Criteria | Specimens collected in gel separator tubes or have gross lipemia or hemolysis are unacceptable. |
| Test Aliases | Lamictal |
| CPT Code(s) | 80175 |
| Lab Section | Reference Lab |